Rosen Terry J insider trades
Rosen Terry J has filed 22 Form 4s with the SEC that we hold, for Arcus Biosciences, Inc. (RCUS) (Chief Executive Officer, Director) and IDEAYA Biosciences, Inc. (IDYA) (Director). Across all of them we count 1 purchase worth $201.6K and 13 sales worth $2.0M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($1.2M). The largest single trade was a sale of 28,947 shares of Arcus Biosciences, Inc. worth $633.4K, dated 2025-12-16. The first filing on our record is dated 2021-12-20 and the latest 2026-06-18.
Arcus Biosciences, Inc. (RCUS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-12-16 | S, sale reported on Form 4 | 1,680 | $66.5K | 2021-12-20 |
| 2021-12-16 | S, sale reported on Form 4 | 619 | $25.0K | 2021-12-20 |
| 2021-12-17 | S, sale reported on Form 4 | 653 | $25.3K | 2021-12-20 |
| 2021-12-17 | S, sale reported on Form 4 | 417 | $16.5K | 2021-12-20 |
| 2021-12-17 | S, sale reported on Form 4 | 808 | $32.8K | 2021-12-20 |
| 2021-12-17 | S, sale reported on Form 4 | 1,065 | $44.1K | 2021-12-20 |
| 2022-06-16 | S, sale reported on Form 4 | 4,241 | $87.9K | 2022-06-21 |
| 2022-06-17 | S, sale reported on Form 4 | 1,361 | $29.5K | 2022-06-21 |
| 2022-06-17 | S, sale reported on Form 4 | 3,252 | $72.5K | 2022-06-21 |
| 2022-12-16 | S, sale reported on Form 4 | 10,983 | $336.7K | 2022-12-16 |
| 2022-12-16 | S, sale reported on Form 4 | 2,060 | $64.3K | 2022-12-16 |
| 2025-02-27 | P, purchase reported on Form 4 | 19,800 | $201.6K | 2025-02-27 |
| 2025-12-16 | S, sale reported on Form 4 | 28,947 | $633.4K | 2025-12-18 |
| 2025-12-17 | S, sale reported on Form 4 | 25,744 | $570.5K | 2025-12-18 |
IDEAYA Biosciences, Inc. (IDYA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1182473) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms